The growth hormone axis explained: pituitary, GHRH, and IGF-1
The short version: a dispatcher, a driver, and a delivery receipt.
TL;DR
- The growth hormone axis is the chain that connects the hypothalamus, pituitary, and liver.
- GHRH from the hypothalamus tells the pituitary to release growth hormone.
- Growth hormone then prompts the liver to make IGF-1, which carries most of the downstream effect.
What it is
The growth hormone axis (in plain English: the team of glands and signals that regulate growth hormone in adults) is a three-step relay. The hypothalamus is the dispatcher; the pituitary is the driver; the liver and other tissues sign for the package and report back. The technical name is the somatotropic axis. The same axis controls how the body uses energy, repairs tissue, and builds lean mass — well into adulthood.
How it works
Picture a small dispatcher (the hypothalamus) sitting at the base of the brain. Several times a day — and especially at night during deep sleep — the dispatcher radios down to the pituitary using a peptide called GHRH (in plain English: growth hormone releasing hormone). The pituitary responds by releasing growth hormone (in plain English: a 191-amino-acid hormone that travels through the bloodstream). Growth hormone then reaches the liver, which produces IGF-1 (in plain English: insulin-like growth factor 1, the hormone that mediates most of growth hormone’s downstream effects on tissue) (Veldhuis et al., J Clin Endocrinol Metab, 2009).
Who asks about it
People ask this because every growth hormone peptide — sermorelin, CJC-1295, ipamorelin, tesamorelin — acts on this axis somewhere. Knowing the relay helps you understand what each peptide is actually doing.
What the research says
Growth hormone secretion declines roughly 14 percent per decade of adult life as documented in the somatotropic axis literature (Veldhuis et al., J Clin Endocrinol Metab, 2009). The Endotext review on growth hormone physiology describes the pulsatile pattern of GH release, the role of feedback loops via somatostatin, and the central role of IGF-1 as the downstream effector (Endotext, Growth Hormone Physiology, 2024).
What to know before considering it
When a clinician runs an IGF-1 test, they are reading the receipt at the end of the relay. A normal IGF-1 generally means the axis is intact. A low IGF-1 in an adult with appropriate symptoms can prompt further testing. Peptides that act on the axis aim to nudge the dispatcher or the driver — not replace them.
The Halftime POV
Understanding the relay turns peptide protocols from a guessing game into a system you can reason about. Three steps. Three signals. One receipt.
Related reading:
- Sermorelin explained: the GHRH analog
- How sermorelin signals growth hormone release
- IGF-1 lab test: what the number means
FAQ
Q: What is the growth hormone axis? A: The growth hormone axis is the chain of organs that produce, regulate, and respond to growth hormone: hypothalamus, pituitary gland, and liver. The hypothalamus releases GHRH, the pituitary releases GH in response, and the liver responds by making IGF-1.
Q: What is GHRH? A: GHRH (growth hormone releasing hormone) is a small peptide produced in the hypothalamus that signals the pituitary to release growth hormone in pulses, mostly at night during deep sleep.
Q: What is IGF-1? A: IGF-1 (insulin-like growth factor 1) is a hormone made primarily by the liver in response to growth hormone. It is the downstream signal that mediates most of growth hormone’s effects on tissue.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
